table of content
1 Introduction to Research & Analysis Reports
1.1 Cell Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy CDMO Overall Market Size
2.1 Global Cell Therapy CDMO Market Size: 2022 VS 2032
2.2 Global Cell Therapy CDMO Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Therapy CDMO Players in Global Market
3.2 Top Global Cell Therapy CDMO Companies Ranked by Revenue
3.3 Global Cell Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cell Therapy CDMO Market Size Markets, 2022 & 2032
4.1.2 Stem Cell
4.1.3 Non-Stem Cell
4.2 By Type - Global Cell Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cell Therapy CDMO Revenue, 2023-2032
4.2.3 By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy CDMO Market Size, 2022 & 2032
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cell Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cell Therapy CDMO Revenue, 2023-2032
5.2.3 By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Cell Therapy CDMO Market Size, 2022 & 2032
6.2 By Region - Global Cell Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cell Therapy CDMO Revenue, 2023-2032
6.2.3 By Region - Global Cell Therapy CDMO Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Cell Therapy CDMO Revenue, 2018-2032
6.3.2 US Cell Therapy CDMO Market Size, 2018-2032
6.3.3 Canada Cell Therapy CDMO Market Size, 2018-2032
6.3.4 Mexico Cell Therapy CDMO Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Cell Therapy CDMO Revenue, 2018-2032
6.4.2 Germany Cell Therapy CDMO Market Size, 2018-2032
6.4.3 France Cell Therapy CDMO Market Size, 2018-2032
6.4.4 U.K. Cell Therapy CDMO Market Size, 2018-2032
6.4.5 Italy Cell Therapy CDMO Market Size, 2018-2032
6.4.6 Russia Cell Therapy CDMO Market Size, 2018-2032
6.4.7 Nordic Countries Cell Therapy CDMO Market Size, 2018-2032
6.4.8 Benelux Cell Therapy CDMO Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Cell Therapy CDMO Revenue, 2018-2032
6.5.2 China Cell Therapy CDMO Market Size, 2018-2032
6.5.3 Japan Cell Therapy CDMO Market Size, 2018-2032
6.5.4 South Korea Cell Therapy CDMO Market Size, 2018-2032
6.5.5 Southeast Asia Cell Therapy CDMO Market Size, 2018-2032
6.5.6 India Cell Therapy CDMO Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Cell Therapy CDMO Revenue, 2018-2032
6.6.2 Brazil Cell Therapy CDMO Market Size, 2018-2032
6.6.3 Argentina Cell Therapy CDMO Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy CDMO Revenue, 2018-2032
6.7.2 Turkey Cell Therapy CDMO Market Size, 2018-2032
6.7.3 Israel Cell Therapy CDMO Market Size, 2018-2032
6.7.4 Saudi Arabia Cell Therapy CDMO Market Size, 2018-2032
6.7.5 UAE Cell Therapy CDMO Market Size, 2018-2032
7 Players Profiles
7.1 Charles River
7.1.1 Charles River Corporate Summary
7.1.2 Charles River Business Overview
7.1.3 Charles River Cell Therapy CDMO Major Product Offerings
7.1.4 Charles River Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Charles River Key News
7.2 The Discovery Labs
7.2.1 The Discovery Labs Corporate Summary
7.2.2 The Discovery Labs Business Overview
7.2.3 The Discovery Labs Cell Therapy CDMO Major Product Offerings
7.2.4 The Discovery Labs Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 The Discovery Labs Key News
7.3 BIOCENTRIQ
7.3.1 BIOCENTRIQ Corporate Summary
7.3.2 BIOCENTRIQ Business Overview
7.3.3 BIOCENTRIQ Cell Therapy CDMO Major Product Offerings
7.3.4 BIOCENTRIQ Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 BIOCENTRIQ Key News
7.4 FUJIFILM Diosynth Biotechnologies
7.4.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Major Product Offerings
7.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 FUJIFILM Diosynth Biotechnologies Key News
7.5 Exothera
7.5.1 Exothera Corporate Summary
7.5.2 Exothera Business Overview
7.5.3 Exothera Cell Therapy CDMO Major Product Offerings
7.5.4 Exothera Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 Exothera Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell Therapy CDMO Major Product Offerings
7.6.4 WuXi AppTec Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTec Key News
7.7 Pharmaron
7.7.1 Pharmaron Corporate Summary
7.7.2 Pharmaron Business Overview
7.7.3 Pharmaron Cell Therapy CDMO Major Product Offerings
7.7.4 Pharmaron Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Pharmaron Key News
7.8 OBiO
7.8.1 OBiO Corporate Summary
7.8.2 OBiO Business Overview
7.8.3 OBiO Cell Therapy CDMO Major Product Offerings
7.8.4 OBiO Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 OBiO Key News
7.9 Cell Therapies
7.9.1 Cell Therapies Corporate Summary
7.9.2 Cell Therapies Business Overview
7.9.3 Cell Therapies Cell Therapy CDMO Major Product Offerings
7.9.4 Cell Therapies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Cell Therapies Key News
7.10 AGC Biologics
7.10.1 AGC Biologics Corporate Summary
7.10.2 AGC Biologics Business Overview
7.10.3 AGC Biologics Cell Therapy CDMO Major Product Offerings
7.10.4 AGC Biologics Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 AGC Biologics Key News
7.11 Cytiva
7.11.1 Cytiva Corporate Summary
7.11.2 Cytiva Business Overview
7.11.3 Cytiva Cell Therapy CDMO Major Product Offerings
7.11.4 Cytiva Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cytiva Key News
7.12 Helixmith
7.12.1 Helixmith Corporate Summary
7.12.2 Helixmith Business Overview
7.12.3 Helixmith Cell Therapy CDMO Major Product Offerings
7.12.4 Helixmith Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 Helixmith Key News
7.13 ThermoGenesis
7.13.1 ThermoGenesis Corporate Summary
7.13.2 ThermoGenesis Business Overview
7.13.3 ThermoGenesis Cell Therapy CDMO Major Product Offerings
7.13.4 ThermoGenesis Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 ThermoGenesis Key News
7.14 Anemocyte
7.14.1 Anemocyte Corporate Summary
7.14.2 Anemocyte Business Overview
7.14.3 Anemocyte Cell Therapy CDMO Major Product Offerings
7.14.4 Anemocyte Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Anemocyte Key News
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Corporate Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Cell Therapy CDMO Major Product Offerings
7.15.4 Thermo Fisher Scientific Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific Key News
7.16 CBM
7.16.1 CBM Corporate Summary
7.16.2 CBM Business Overview
7.16.3 CBM Cell Therapy CDMO Major Product Offerings
7.16.4 CBM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 CBM Key News
7.17 Bio Elpida
7.17.1 Bio Elpida Corporate Summary
7.17.2 Bio Elpida Business Overview
7.17.3 Bio Elpida Cell Therapy CDMO Major Product Offerings
7.17.4 Bio Elpida Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Bio Elpida Key News
7.18 Genezen
7.18.1 Genezen Corporate Summary
7.18.2 Genezen Business Overview
7.18.3 Genezen Cell Therapy CDMO Major Product Offerings
7.18.4 Genezen Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 Genezen Key News
7.19 CCRM
7.19.1 CCRM Corporate Summary
7.19.2 CCRM Business Overview
7.19.3 CCRM Cell Therapy CDMO Major Product Offerings
7.19.4 CCRM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 CCRM Key News
7.20 RoslinCT
7.20.1 RoslinCT Corporate Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy CDMO Major Product Offerings
7.20.4 RoslinCT Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 RoslinCT Key News
7.21 GenScript ProBio
7.21.1 GenScript ProBio Corporate Summary
7.21.2 GenScript ProBio Business Overview
7.21.3 GenScript ProBio Cell Therapy CDMO Major Product Offerings
7.21.4 GenScript ProBio Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 GenScript ProBio Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
